pyrroles has been researched along with Behcet Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, Y; Li, C; Li, L; Liu, J; Sun, L; Zeng, X; Zhang, F; Zhao, Y; Zheng, W | 1 |
| Borlu, M; Dogan, A; Duran, M; Gunebakmaz, O; Heyit, T; Inanc, MT; Kalay, N; Kasapkara, HA; Kaya, MG; Oguzhan, A; Ozdogru, I; Yarlıoglues, M | 1 |
| Hashimoto, T; Inayama, Y; Iwatsubo, K; Kihara, M; Kokuho, T; Kuji, T; Oshikawa, J; Tamura, K; Tanaka, K; Toya, Y; Umemura, S; Yabana, M; Yanagi, M; Yoshida, S | 1 |
2 trial(s) available for pyrroles and Behcet Syndrome
| Article | Year |
|---|---|
A pilot study of tofacitinib for refractory Behçet's syndrome.
Topics: Adult; Behcet Syndrome; Female; Humans; Male; Middle Aged; Pilot Projects; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles | 2020 |
Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behçet's disease.
Topics: Adult; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Behcet Syndrome; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Lisinopril; Male; Placebo Effect; Pyrroles; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left | 2010 |
1 other study(ies) available for pyrroles and Behcet Syndrome
| Article | Year |
|---|---|
Behçet's disease complicated by IgA nephropathy with nephrotic syndrome.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atorvastatin; Behcet Syndrome; Benzimidazoles; Biphenyl Compounds; Dilazep; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nephrotic Syndrome; Pyrroles; Tetrazoles; Vasodilator Agents | 2008 |